Nektar Therapeutics (NASDAQ:NKTR)

58.41
Delayed Data
As of Jun 18
 +0.55 / +0.95%
Today’s Change
17.51
Today|||52-Week Range
111.36
-2.19%
Year-to-Date

Today’s Trading

Previous close57.86
Today’s open57.38
Day’s range56.57 - 58.81
Volume3,799,444
Average volume (3 months)3,818,517
Market cap$13.9B
Data as of 4:00pm ET, 06/18/2018

Growth & Valuation

Earnings growth (last year)+43.64%
Earnings growth (this year)+544.01%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)+86.00%
P/E ratioNM
Price/Sales30.27
Price/Book147.00

Competitors

 Today’s
change
Today’s
% change
ONCESpark Therapeutics I...-0.82-1.06%
----
XONIntrexon Corp+0.31+1.92%
BPMCBlueprint Medicines ...-1.59-2.29%
Data as of 4:02pm ET, 06/18/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$3.91
Annual revenue (last year)$307.7M
Annual profit (last year)-$96.7M
Net profit margin-31.42%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts